Credit Suisse analyst Christoph Gretler raised the firm’s price target on Fresenius Medical to EUR 45 from EUR 42 and keeps a Neutral rating on the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on FMS:
- Fresenius Medical price target raised to EUR 38 from EUR 36 at Barclays
- Fresenius Medical price target raised to EUR 54 from EUR 50.90 at Berenberg
- Fresenius Medical price target raised to EUR 38 from EUR 28.60 at JPMorgan
- Fresenius Medical resumed with a Neutral at Citi
- Fresenius Medical price target raised to $28 from $26 at Truist